Thursday, June 18, 2015

Top 10 Industrial Disributor Companies To Buy For 2015

Popular Posts: Apple Earnings Set to Give AAPL Stock a LiftApple’s So-So Quarter Could Kill AAPL’s Mojo3 Global Food & Beverage Giants on the Ropes Recent Posts: CYNK Stock Crushed After Trading Halt Is Lifted Don’t Get Burned by Under Armour Stock Stock Showdown: Ford vs. GM stock View All Posts CYNK Stock Crushed After Trading Halt Is Lifted

CYNK Technology (CYNK) resumed trading Friday, and plenty of shareholders probably wish it hadn’t as they watched CYNK stock plunge nearly 85%.

Hot Electric Utility Stocks To Invest In Right Now: Theravance Inc.(THRX)

Theravance, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule medicines for various therapeutic areas, including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. The company?s key development programs with GlaxoSmithKline (GSK) include the RELOVAIR, a Phase 3 clinical trial program for the treatment of patients with chronic obstructive pulmonary disease (COPD) and/or asthma; the LAMA/LABA program, a Phase 3 COPD program; and the Bifunctional Muscarinic Antagonist-beta2 Agonist (MABA) program, a Phase 2b program for the treatment of COPD, as well as Peripherally Selective Mu-Opioid Receptor Antagonist (P Advisors' Opinion:

  • [By Sean Williams]

    Perhaps the most exciting new treatment to hit the market in years was recently approved by the FDA. Developed by GlaxoSmithKline (NYSE: GSK  ) and Theravance (NASDAQ: THRX  ) , Breo Ellipta is a dry powder drug delivered by inhaler and meant to provide long-term relief of air-flow obstruction and reduce COPD exacerbations. The two companies are collaborating on a handful of potentially revolutionary new COPD treatments that combine Theravance's long-acting beta-2 agonists with Glaxo's long-acting muscarinic antagonists. Its next treatment, Breo Anoro, is currently under review by the FDA.

  • [By Jonas Elmerraji]

    First up is $4 billion biopharmaceutical firm Theravance (THRX). It's been one heck of a year already for THRX's shareholders. Since the calendar flipped over to January, shares of the firm have rallied more than 75%. But the setup forming in shares points to even higher ground for the final quarter of 2013.

    That's because Theravance is currently forming an ascending triangle pattern, a bullish setup that's formed by a horizontal resistance level above shares at $42 and uptrending support to the downside. Basically, as Theravance bounces in between those two technical levels, it's getting squeezed closer and closer to a breakout above that $42 resistance level. When that happens, traders have a buy signal.

    Whenever you're looking at any technical price pattern, it's critical to think in terms of those buyers and sellers. Ascending triangles and other pattern names are a good quick way to explain what's going on in a stock, but they're not the reason it's tradable. Instead, it all comes down to supply and demand for shares.

    That $42 is a price where there has been an excess of supply of shares; in other words, it's a place where sellers have been more eager to step in and take gains than buyers have been to buy. That's what makes a breakout above it so significant -- the move means that buyers are finally strong enough to absorb all of the excess supply above that price level.

    Don't be early on this trade.

  • [By Sean Williams]

    Finally, Theravance (NASDAQ: THRX  ) made waves after announcing that it would be splitting its business into two separate components: Royalty Management, which will focus on drugs currently in the pipeline in collaboration with GlaxoSmithKline, and Theravance BioPharma, which will continue its line of small-molecule rare disease research. Clearly, this gives investors more visibility of where revenue and profit are coming from, but I think it gives Glaxo even more reason to gobble up the Royalty Management segment because now it doesn't have to buy the remaining pipeline of rare disease research.

  • [By Sean Williams]

    A revolutionary COPD treatment?
    On Wednesday, chronic obstructive pulmonary disease, or COPD, treatment collaborators GlaxoSmithKline (NYSE: GSK  ) and Theravance (NASDAQ: THRX  ) are set to go before the FDA's panel with their combo Breo Ellipta. This revolutionary drug combines Theravance's long-acting beta-2 agonists with Glaxo's long-acting muscarinic antagonists into a dry powder inhaler to provide long-term COPD relief.

Top 10 Industrial Disributor Companies To Buy For 2015: MAKO Surgical Corp.(MAKO)

MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific osteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment. The company?s MAKOplasty partial knee arthroplasty solution enables resurfacing of one or two specific diseased compartments of the joint, preserving more soft tissue and healthy bone of the knee; and MAKOplasty Total Hip Arthroplasty, a surgical solution that enables orthopedic surgeons to pe rform total hip arthroplasty. In addition, it offers tactile guidance system, which allows orthopedic surgeons to treat degenerative knee osteoarthritis from early-stage unicompartmental degeneration through mid-stage multicompartmental degeneration with a modular knee implant system; and RESTORIS family of implants for use in single and bicompartmental knee resurfacing procedures. The company markets its products through direct sales force, as well as through independent orthopedic product agents and distributors. MAKO Surgical Corp. was founded in 2004 and is headquartered in Fort Lauderdale, Florida.

Advisors' Opinion:
  • [By Steve Symington]

    In addition, unlike incredibly expensive medical robots from the likes of�MAKO Surgical� (NASDAQ: MAKO  ) and�Intuitive Surgical� (NASDAQ: ISRG  ) -- the costs for which can easily run into the seven-figure range -- iRobot's RP-VITA was to be available through a leasing model for a very reasonable $4,000 to $6,000 per month.

  • [By Lauren Pollock]

    Among the companies with shares expected to actively trade in Wednesday’s session are Mako Surgical Corp.(MAKO), Ascena Retail Group Inc.(ASNA) and Oncothyreon Inc.(ONTY)

  • [By Sean Williams]

    What's more, what goes for Intuitive Surgical likely goes double for MAKO Surgical (NASDAQ: MAKO  ) , a robotic surgical device maker for orthopedic knee and hip procedures. Because MAKO is currently unprofitable the boom and bust it could experience because of its unique niche versus the effects of Obamacare could really be a huge catalyst. Take clues from MAKO's management as another indicator of where Intuitive may head next and keep your eyes fixated on Intuitive's July 18 report.

  • [By Rich Smith]

    Fort Lauderdale, Fla.-based MAKO Surgical (NASDAQ: MAKO  ) shares were surging today on news that the company has settled its patent infringement dispute with Stanmore Implants Worldwide.

Top 10 Industrial Disributor Companies To Buy For 2015: Hatteras Financial Corp (HTS)

Hatteras Financial Corp., incorporated on September 19, 2007, is an externally managed mortgage real estate investment trust (REIT) that invests primarily in single-family residential mortgage pass-through securities guaranteed or issued by the United States Government agency (such as the Government National Mortgage Association (Ginnie Mae)), or by the United States Government-sponsored entity (such as the Federal National Mortgage Association, (Fannie Mae)), and the Federal Home Loan Mortgage Corporation, (Freddie Mac)). The Company is externally managed and advised by its manager, Atlantic Capital Advisors LLC.

The Company focuses on agency securities consisting of mortgage loans with short durations. The agency securities consist of mortgages that have principal and interest payments guaranteed by Ginnie Mae, Fannie Mae or Freddie Mac. It invests in both fixed-rate and adjustable-rate agency securities. Adjustable rate mortgages (ARMs) are mortgages that have floating interest rates that reset on a specific time schedule, such as monthly, quarterly or annually, based on a specified index, such as the 12-month moving average of the one-year constant maturity United States Treasury rate (CMT) or the London Interbank Offered Rate (LIBOR). The ARMs it generally invests in, sometimes referred to as hybrid ARMS, have interest rates that are fixed for an initial period (typically three, five, seven or 10 years) and then reset annually thereafter to an increment over a pre-determined interest rate index.

Advisors' Opinion:
  • [By Amanda Alix]

    When Hatteras Financial (NYSE: HTS  ) declared second-quarter�earnings earlier this week, it was not a pretty sight, as earnings per share missed the mark by $0.04. But that wasn't what set the stage for the carnage that spread throughout the sector: Hatteras reported a huge -- more than 20% -- drop in book value from the first quarter, sending the stock down more than 10% on Wednesday.

  • [By Rich Duprey]

    Single-family-housing REIT�Hatteras Financial (NYSE: HTS  ) announced yesterday its second-quarter dividend of $0.70 per share, the same rate it's paid for the past two quarters after cutting the payout 12.5% from $0.80 per share.

Top 10 Industrial Disributor Companies To Buy For 2015: Richardson Electronics Ltd. (RELL)

Richardson Electronics, Ltd. engages in the provision of engineered solutions; and distribution of electronic components to the electron device and display systems markets. Its Electron Device Group provides engineered solutions, and distributes electronic components to customers in various markets, such as steel, automotive, textile, plastics, semiconductor manufacturing, and broadcast industries. It designs solutions for various applications comprising industrial heating, laser technology, semiconductor manufacturing equipment, radar, and welding. This division also provides replacement products for systems using electron tubes, as well as offer design and assembly services for new systems employing semiconductor manufacturing equipment. The company?s Canvys division provides integrated display products, workstations, and value-added services to the healthcare, industrial and medical original equipment manufacturers, and digital signage markets. Its display solutions con sist of touch screens, protective panels, custom enclosures, specialized cabinet finishes, application specific software packages, and display products. This division also partners with hardware vendors and offers liquid crystal displays, mounting devices, and customized computing platforms. Richardson Electronics offers its solutions in North America, the Asia Pacific, Europe, and Latin America. The company was founded in 1947 and is headquartered in LaFox, Illinois.

Advisors' Opinion:
  • [By Monica Gerson]

    Richardson Electronics (NASDAQ: RELL) is estimated to post its Q1 earnings.

    NovaGold Resources (NYSE: NG) is expected to post a Q3 loss at $0.03 per share.

  • [By Tim Melvin]

    The safe and cheap undervalued stocks will go right up, but your chances of being destroyed when the party is over are diminished. Stocks like Richardson Electronics (RELL) and Transworld Entertainment (TWMC) have the ability to go up as the market bubbles higher but their asset value will act as sort of a floor in a decline.

  • [By gurujx]

    Richardson Electronics (RELL) Reached the Three-Year Low of $11.13

    The prices of Richardson Electronics (RELL) shares have declined to close to the three-year low of $11.13, which is 31.1% off the three-year high of $15.40.

Top 10 Industrial Disributor Companies To Buy For 2015: Ecotality Inc.(ECTY)

ECOtality, INC., through its subsidiaries, provides clean electric transportation and storage technologies in the United States and internationally. It offers electric vehicle supply equipment for on-road vehicular applications under the Blink name; and advanced fast-charge systems for material handling, airport ground support equipment, and various motive applications under the Minit-Charger name, as well as engages in the development, manufacture, assembly, and sale of specialty solar products, advanced battery systems, and hydrogen and fuel cell systems. The company also provides testing, engineering, and consulting services, including the advanced vehicle testing activities; the EV Micro-Climate process, a planning and consulting program for municipal planning organizations and utilities; bridge power manager systems; and EV network management and software solutions. In addition, it offers energy engineering services comprising hydrogen, solar, battery, coal gasificati on, and energy delivery infrastructure; hydrogen internal combustion engine vehicle conversions; industrial battery systems; specialty solar solutions; specialty thin-sealed lead battery products; and third-party hydrogen and education related products. Further, the company operates an online retail store that provides a range of fuel cell products, such as fuel cell stacks, systems, component parts, and educational materials. It serves commercial, industrial, institutional, governmental, and utility sector consumers. The company was formerly known as Alchemy Enterprises, Ltd. and changed its name to ECOtality, Inc. in November 2006. ECOtality, Inc. was founded in 1999 and is headquartered in San Francisco, California.

Advisors' Opinion:
  • [By CRWE]

    About ECOtality

    ECOtality, Inc. (Nasdaq:ECTY), headquartered in San Francisco, California, is a leader in clean electric transportation and storage technologies. Through innovation, acquisitions, and strategic partnerships, ECOtality accelerates the market applicability of advanced electric technologies to replace carbon-based fuels. For more information about ECOtality, please visit www.ecotality.com.

    Forward-Looking Statements

Top 10 Industrial Disributor Companies To Buy For 2015: Trulia Inc (TRLA)

Trulia, Inc. is a real estate search engine company. The Company helps in finding homes for sale and provides real estate information. The Company is also a tool for real estate professionals to market their listings, view real estate data and promote their services. It provides local information, community insights, market data and national listings. Effective August 20, 2013, Trulia Inc acquired the entire interest of Market Leader Inc.

Trulia.com is an online real estate site focused on buyers, sellers and renters with tools to help them find the right home. The Company�� Website, www.trulia.com, is a search engine for buying and renting homes, advising homes and mortgages. The Company is headquartered in downtown San Francisco and is backed by Accel Partners and Sequoia Capital.

Advisors' Opinion:
  • [By Rich Duprey]

    Critics of real estate portals�Zillow (NASDAQ: Z  ) and�Trulia (NYSE: TRLA  ) �have long thought both companies represented poor business models, and the $3.5 billion all-stock merger of the two isn't about to change anyone's mind.�Although there's been a lot of ink spilled about the benefits to accrue from combining the two real estate info houses, this may end up being less a fortuitous joining of forces and�more like the merger of declining retailers Sears, Roebuck and Kmart that resulted in Sears Holding, which is still a sickly business today.

  • [By Alex Planes]

    What: Shares of Trulia (NYSE: TRLA  ) have risen over 14% today after the company delivered a decent earnings report paired with strong forward guidance.

  • [By Peter Graham]

    The Q3 2014 earnings report for mid cap�online real estate information stock Zillow Inc (NASDAQ: Z), a peer of small cap�Move Inc (NASDAQ: MOVE) which News Corp (NASDAQ: NWSA) is acquiring and small cap�Trulia Inc (NYSE: TRLA) which Zillow is also acquiring, is scheduled for after the market's close on Wednesday (November 5th). Aside from the Zillow Inc earnings report, it should be said that Move Inc reported Q2 2014 earnings on July 29th (revenue rose 7% to $61.3M, average monthly unique users of realtor.com庐's web and mobile sites grew 18% to 31.2M and Non-GAAP Loss Per Share was $0.03 per diluted share verses Non-GAAP Earnings Per Share of $0.11) and Trulia Inc reported Q3 2014 earnings on October 29th (total revenue rose 67% to $67.1M along with an adjusted net loss of $2.8 million, or $0.08 per share on a basic and diluted basis, compared with adjusted net income of $9.1 million, or $0.26 and $0.24 per share on a basic and diluted basis, respectively). The acquisition of Move Inc and Trulia Inc though (assuming the Federal Trade Commission approves the deal)�really leaves Zillow Inc as the main publicly traded online real estate information.�

  • [By WWW.DAILYFINANCE.COM]

    www.ea.com There were plenty of winners and losers this week, including a merger of two fast-growing real estate website operators and a theme park operator taking another hit. Here's a rundown of the week's smartest moves and biggest blunders. Tesla Motors (TSLA) -- Winner The country's coolest automaker -- and one of the hottest stocks over the past two years -- continues to grow in popularity. The maker of luxury plug-in electric cars posted a better than expected adjusted profit in its latest quarter, with revenue nearly doubling. Tesla is on track to deliver 35,000 of its Model S sedans this year. It also announced on Thursday that it expects to produce 60,000 cars next year as the Model X crossover joins its lineup. Tesla's rich multiples aren't for the squeamish, but the company seems to be revolutionizing the automotive industry. One can only imagine how things will be when it starts rolling out its more reasonably priced Model III car in three years. SeaWorld (SEAS) -- Loser SeaWorld can't seem to catch a break, even when misfortune results in denial. SeaWorld and Southwest Airlines (LUV) are ending their marketing partnership after 26 years. The relationship had Southwest promoting the marine life theme park operator on some of its planes and SeaWorld offering Southwest-branded relaxation and charging stations. Anti-SeaWorld protestors had demonstrated at Southwest's headquarters earlier this year, and more than 32,000 people had signed an online petition at change.org urging the air carrier to end its association with SeaWorld. However, this already unfortunate story makes the cut this week because of SeaWorld's explanation on why the two companies will part ways when the latest contract is up at the end of the year. "With an increasing international visitor base, SeaWorld is looking to focus on new and growing markets in Latin America and Asia, among others," SeaWorld explains in a joint statement with Southwest, almost as if it's saying that

Top 10 Industrial Disributor Companies To Buy For 2015: GigaMedia Limited (GIGM)

Gigamedia Limited, through its subsidiaries, primarily engages in the operation of online games for online game players in Asia. The company provides a portfolio of online games, including MahJong, a traditional Chinese tile game; MMORPG, an Internet-based computer game; advanced casual games; and card, chance-based, and simple casual games. It also develops and licenses online poker, casino, and sports betting gaming software solutions, as well as offers application services for the online poker and casino markets primarily in the continental European markets. The company has strategic alliances with SoftStar Entertainment Inc., Neostorm Holdings Limited, XLGames Inc., Access China Holding Limited, Gorilla Banana Entertainment Corp., JC Entertainment Corporation, Possibility Space Incorporated, East Gate Media Contents & Technology Fund, and BetClic. GigaMedia Limited was founded in 1997 and is headquartered in Taipei, Taiwan.

Advisors' Opinion:
  • [By Eric Volkman]

    GigaMedia (NASDAQ: GIGM  ) results for the company's fiscal Q4 and 2012 have been released. For the quarter, revenue was $4.8 million, down by 34% from the $7.4 million in the same period the previous year. Attributable net loss, however, narrowed considerably to $15.4 million ($0.30 per diluted share) from Q4 2011's shortfall of $51.3 million ($1.01).

No comments:

Post a Comment

.